Australia markets open in 2 hours 25 minutes

Prescient Therapeutics Limited (PTX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1600+0.0150 (+10.34%)
At close: 04:10PM AEDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Operating expenses
Research development
3,400
3,400
2,495
2,760
3,682
Selling general and administrative
3,699
3,699
2,932
1,734
1,863
Total operating expenses
7,101
7,101
5,428
4,495
5,545
Operating income or loss
-7,101
-7,101
-5,428
-4,495
-5,545
Interest expense
4.19
6.534
10.615
4.19
3.301
Total other income/expenses net
1,944
1,944
1,223
1,107
1,679
Income before tax
-5,117
-5,117
-4,149
-3,321
-3,797
Income tax expense
0
0
0
0
0
Income from continuing operations
-5,117
-5,117
-4,149
-3,321
-3,797
Net income
-5,117
-5,117
-4,149
-3,321
-3,797
Net income available to common shareholders
-5,117
-5,117
-4,149
-3,321
-3,797
Basic EPS
-
-
-0.01
-0.01
-0.02
Diluted EPS
-
-
-0.01
-0.01
-0.02
Basic average shares
-
-
611,805
394,261
244,545
Diluted average shares
-
-
611,805
394,261
244,545
EBITDA
-
-5,109
-4,138
-3,316
-3,794